Publication | Open Access
Effect of rifaximin, probiotics, and l-ornithine l-aspartate on minimal hepatic encephalopathy: A randomized controlled trial
82
Citations
17
References
2014
Year
Prevalence of MHE is high in patients with cirrhosis of liver. Rifaximin, LOLA, and probiotics are better than giving placebo in patients with MHE.
| Year | Citations | |
|---|---|---|
Page 1
Page 1